Latest Fibromyalgia Research: Breakthroughs and Insights
Fibromyalgia has long been a puzzle for both patients and healthcare providers. If you're grappling with this condition, you know how frustrating it can be to manage the pain, fatigue, and other symptoms that seem to have no clear cause. The good news is that the latest fibromyalgia research is shedding new light on this complex disorder. Scientists are making exciting breakthroughs that could change how we understand and treat fibromyalgia, giving hope to millions who struggle with it daily.
Written by Rowan Bailey
Published on 30th July 2024
*Disclaimer*
We cannot discuss medical claims with regards to CBD. We regularly get asked by our customers so try to provide the best information we can whilst navigating this strict landscape that we fully support. We link to and quote from studies below, but it is vital to do your own research and to keep an eye out for recent studies. Beyond that, we're not medical professionals, essentially strangers on the internet. So always do your own research!
In this article, we'll explore the cutting-edge findings that are reshaping our view of fibromyalgia. You'll learn about the potential autoimmune basis of the condition, how your central nervous system might play a key role, and the interplay between your genes and environment. We'll also look at new approaches to pain management and treatment options that could make a real difference in your life. Whether you're dealing with fibro fog, searching for better ways to handle your symptoms, or simply want to understand this condition better, this overview of the latest research will give you valuable insights and reasons for optimism.
Autoimmune Basis of Fibromyalgia
Recent research suggests that fibromyalgia may have an autoimmune basis, challenging the widely held view that it originates in the brain 1. Scientists hypothesize that altered levels of cytokines and the higher prevalence of fibromyalgia among those with autoimmune rheumatological conditions caused by autoantibodies point to a potential autoimmune component 1.
A groundbreaking study by Goebel et al. demonstrated that transferring immunoglobulin G (IgG) from fibromyalgia patients to mice resulted in the development of characteristic fibromyalgia symptoms, including increased sensitivity to pain and cold, reduced movement, and decreased grip strength 1 2. Importantly, IgG from healthy controls had no effect on the mice, and the symptoms reversed after stopping the administration of fibromyalgia patient IgG 1 2.
The study also found that fibromyalgia IgG sensitized nerves without causing systemic inflammation or cytokine differences 1. Additionally, the IgG showed increased affinity to peripheral glial cells and neurons, affecting dorsal root ganglia and decreasing nerve fiber density in the skin 1.
These findings suggest that antibody-dependent processes underpin the characteristic tenderness and thermal hypersensitivities experienced by fibromyalgia patients 2. The successful replication of results using British and Swedish patients, as well as the observed effects in both female and male mice, strengthen the validity of the study 1.
The implications of this research are profound, as establishing fibromyalgia as an autoimmune disorder could transform how we view and treat the condition 3. It opens up new avenues for therapeutic options, such as reducing total IgG levels through plasmapheresis or immunoadsorption, or targeting specific autoreactive IgG 2.
Furthermore, this research could pave the way for the development of blood-based diagnostic tests for fibromyalgia, which are currently lacking 3. Identifying the specific autoantibodies involved in fibromyalgia pathophysiology could lead to more accurate and efficient diagnosis.However, it is important to note that further research is needed to confirm these findings and address limitations, such as sample size and the need for replication 4. Additionally, identifying the specific autoantibodies responsible for fibromyalgia symptoms remains a challenge, as no consistent autoantibody was found in the initial testing of a small sample of patients 4.Despite these limitations, the autoimmune basis of fibromyalgia presents an exciting new direction for research and treatment. As scientists continue to investigate the role of autoreactive IgG in fibromyalgia pathophysiology, there is hope for the millions of people affected by this debilitating condition 3.
Central Nervous System Involvement
Recent research suggests that fibromyalgia is associated with central nervous system abnormalities, including altered pain processing, neurotransmitter imbalances, and brain imaging findings that differ from healthy controls 1 5.
- Pain Processing Abnormalities: Patients with fibromyalgia exhibit allodynia (heightened sensitivity to stimuli that are not normally painful) and hyperalgesia (an increased response to painful stimuli) 1. These abnormalities in pain processing are thought to result from central amplification of pain signals, characterized by increased excitability of central neurons and reduced pain inhibitory mechanisms 1 5.
Experimental pain testing has demonstrated that fibromyalgia patients perceive pain at a lower threshold than healthy controls in response to pressure and other stimuli 5. Functional neuroimaging studies support these findings, showing that patients with fibromyalgia have greater regional cerebral blood flow in areas of the brain associated with pain processing at lower pain-producing pressures compared to controls 5.
Neurotransmitter Imbalances: Fibromyalgia is associated with alterations in levels of neurotransmitters and receptors involved in pain processing pathways 5. Patients with fibromyalgia have been found to have:
1. Increased levels of substance P, nerve growth factor, and brain-derived neurotrophic factor in the cerebrospinal fluid (CSF), indicating increased signaling in ascending, pro-nociceptive pathways 5.
2. Elevated levels of glutamate and other excitatory amino acids in the CSF and brain, which can lead to increased pain sensitization 5.
3. Lower CSF levels of metabolites of serotonin, norepinephrine, and dopamine, suggesting decreased activity of descending, anti-nociceptive pathways 5.
4. Interestingly, while opioid levels are increased in fibromyalgia, opioid receptor binding is decreased, resulting in a net effect of increased baseline endogenous opioidergic activity 5. This finding may help explain why opioids are generally less effective in treating fibromyalgia and other central pain states 5.
Brain imaging findings: Neuroimaging studies have revealed structural and functional brain changes in patients with fibromyalgia compared to healthy controls 1. These findings include:
1. Decreased cortical thickness in regions of the frontal, temporal, and parietal cortex 1.
2. Reduced cortical volume in the left medial frontal cortex and right posterior cingulate cortex 1.
3. Increased fractional anisotropy in white matter tracts such as the corona radiata, corpus callosum, cingulum, and fornix 1.
4. Functional hypoconnectivity between the right midfrontal gyrus and the posterior cerebellum and right crus cerebelli 1.
Subgroup analyzes comparing fibromyalgia patients with and without peripheral nerve involvement (i.e., reduced intraepidermal nerve fiber density) have shown additional brain changes. The subgroup with peripheral nerve pathology exhibited decreased cortical volume in the bilateral pericalcarine cortices, decreased fractional anisotropy in the left posterior limb of the internal capsule and posterior thalamic radiation, and hyperconnectivity between the inferior frontal gyrus, angular gyrus, and posterior parietal cortex 1.
These central nervous system abnormalities, including altered pain processing, neurotransmitter imbalances, and brain imaging findings, provide evidence for the neurogenic origin of chronic widespread pain in fibromyalgia 1 5. Ongoing research aims to further elucidate the role of these central mechanisms in other cardinal symptoms of fibromyalgia, such as fatigue, sleep disturbances, and cognitive dysfunction 5.
R Bailey
I work as a consultant in the CBD and medical cannabis industry whilst also being a medical cannabis patient myself for my Fibromyalgia. I have been in the industry since 2018, and a patient since 2020. Along my journey I have provided educational talks to support groups for fibro across south west Wales, whilst also working in CBD Labs developing products specifically for fibro and other issues.
Genetic and Environmental Factors
Growing evidence suggests that both genetic and environmental factors contribute to the development of fibromyalgia. While specific genes have been identified as potential risk factors, the complex interplay between genes and the environment is believed to play a crucial role in the onset and severity of fibromyalgia symptoms.
Candidate Genes
Researchers have identified several candidate genes that may increase an individual's susceptibility to developing fibromyalgia. These genes are involved in various physiological processes, including pain processing, neurotransmitter regulation, and stress response.
One of the most studied candidate genes is the catechol-O-methyltransferase (COMT) gene, which is involved in the breakdown of neurotransmitters such as dopamine and norepinephrine . Variations in the COMT gene have been associated with increased pain sensitivity and a higher risk of developing fibromyalgia.
Other candidate genes that have been implicated in fibromyalgia include the serotonin transporter gene (SLC6A4) , the transient receptor potential vanilloid 2 (TRPV2) gene , and the opioid receptor mu 1 (OPRM1) gene 4. These genes are involved in pain modulation, neurotransmitter signaling, and the body's response to stress.
Epigenetic Changes
In addition to genetic variations, epigenetic changes have been observed in individuals with fibromyalgia. Epigenetics refers to modifications in gene expression that occur without changes to the underlying DNA sequence. These modifications can be influenced by environmental factors and may contribute to the development of chronic pain conditions like fibromyalgia.
Studies have shown that fibromyalgia patients exhibit a general hypomethylation pattern compared to healthy controls. DNA methylation is an epigenetic mechanism that can alter gene expression. Hypomethylation has been observed in genes involved in DNA repair, immune system function, and membrane transport in fibromyalgia patients .Furthermore, differences in microRNA (miRNA) expression have been found in various tissues of fibromyalgia patients, including cerebrospinal fluid, serum, and peripheral blood mononuclear cells. MiRNAs are small non-coding RNA molecules that regulate gene expression and have been implicated in pain processing and inflammation.
Triggering Events
While genetic and epigenetic factors may predispose individuals to develop fibromyalgia, environmental triggers often play a crucial role in the onset of symptoms. Physical trauma, such as injuries or surgeries, has been identified as a potential triggering event for fibromyalgia 6.
Psychological stress and emotional trauma have also been strongly associated with the development of fibromyalgia . Chronic stress can lead to dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which is involved in the body's stress response and pain modulation .Other potential triggering events include infections, sleep disturbances, and physical or emotional abuse 7 8 . These events may interact with an individual's genetic and epigenetic susceptibility to fibromyalgia, leading to the manifestation of symptoms.
Understanding the complex interplay between genetic, epigenetic, and environmental factors is crucial for unraveling the pathophysiology of fibromyalgia. Further research in this area may lead to the development of personalized treatment approaches and targeted interventions for individuals with this debilitating condition.
CBD for Fibromyalgia symptoms
As you explore options for managing fibromyalgia symptoms, you might be curious about the potential benefits of CBD. Cannabidiol, or CBD, is a compound derived from cannabis that has gained attention for its potential therapeutic effects which are being studied across the world. Unlike THC, CBD doesn't produce a "high" and is being studied for its possible role in pain management and other health concerns 7. By avoiding the 'high' or balancing it with a ratio between THC and CBD, you can manage things day to day without any impairment.
98% of customers would recommend this CBD balm after trying it
All natural & soothing
Conclusion
The latest fibromyalgia research has a profound impact on our understanding and treatment of this complex condition. From uncovering potential autoimmune origins to shedding light on central nervous system involvement, these breakthroughs offer new hope to those grappling with fibromyalgia. The insights into genetic and environmental factors also pave the way for more personalized approaches to manage symptoms and improve quality of life.
As we move forward, these findings open up exciting avenues to explore new treatments and diagnostic methods. While there's still much to learn, the progress made so far gives us reason to be optimistic. For those living with fibromyalgia, these advancements bring us closer to better solutions and a deeper understanding of their experiences, potentially transforming how we approach this challenging condition in the years to come.
Fibromyalgia Research FAQ
References
[1] - https://versusarthritis.org/news/2024/may/our-fibromyalgia-research-highlights/
[2] - https://versusarthritis.org/news/2021/june/research-shows-fibromyalgia-is-likely-a-condition-of-the-immune-system/
[3] - https://www.kcl.ac.uk/news/new-study-shows-fibromyalgia-likely-the-result-of-autoimmune-problems
[4] - https://meassociation.org.uk/2021/07/research-passive-transfer-fibromyalgia/
[5] - https://www.nature.com/subjects/fibromyalgia
[6] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730558/
[7] - https://www.fpm.ac.uk/media/3986
[8] - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068842/
Written by Rowan Bailey
CBD lab geek, medical cannabis patient and consultant.
More related posts
Fibromyalgia, an interview with a support group member
THC or CBD for Fibromyalgia?
Medical Cannabis Fibromyalgia Study Results
Best CBD products for Fibro Pain
Finding balance the natural way
Discover More
Four20 Pharma GMO Medical Cannabis Strain review UK
Garlic, Mushroooms and Onions aren't what you first think of when you think about the smell of cannabis, however upon receiving this I was pleasantly surprised. Certainly a pungent savoury aroma and flavour to this one, but not unpleasant at all. The high 30% THC content has done wonders for me personally but without a harsh vaping experience. The cure has gone a long way to making this a smooth yet potent vape that I would happily continue to use as my night time strain.
Curaleaf Jack Herer 510 Vape Cart Review Medical Cannabis UK
In our opinion, carts are one of the best methods for consuming your THC prescription with ease whilst out and about, or for sudden surges/ flare ups that need immediate help. Not only that, they are amazing at microdosing THC to manage low doses as you need them. The downside? Cost and tolerance... We'll jump into why we have a love hate relationship with these little beauties, but don't worry as a product themselves they are brilliant, it's mainly the price point that we struggle with.
Aurora Pedanios Sourdough 29% Strain Review UK Medical Cannabis
We may be a little late to the Sourdough party so to speak, but we're glad we tried it. This potent strain delivers brilliantly for my pain management whilst being an incredibly smooth vape, something I hadn't anticipated. Beyond that it's unique flavour and well cured flower has got an overly positive reaction from me, but let's jump into the details and see what she looks like under the microscope!
Top Portable Dry Herb Vaporizers for On-the-Go Medical Cannabis in the UK
Are you searching for the best portable dry herb vaporizer in the UK to take your medical cannabis doses on the go? Look no further. As a medical cannabis patient for over three years, I understand the importance of having a reliable, discreet, and efficient device by your side wherever life takes you. Whether you're seeking the ultimate pocket-sized companion for quick sessions or a powerhouse that delivers uncompromising vapour quality, we've got you covered.